Related Experiment Video
Updated: Aug 10, 2026
10:53
Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Anions, membrane resistance and ventricular fibrillation
1Cardiovascular Research Laboratories, King's College University of London, UK.
Journal of Basic and Clinical Physiology and Pharmacology
|January 1, 1994
Summary
Preventing sudden cardiac death, particularly ventricular fibrillation (VF), requires new strategies. Research suggests manipulating chloride homeostasis and altering sarcolemmal membrane resistance offers a novel approach to VF suppression.
Area of Science:
- Cardiology
- Electrophysiology
- Molecular Biology
Background:
- Sudden cardiac death (SCD) remains a significant clinical challenge.
- Current methods for preventing ventricular fibrillation (VF), a primary cause of SCD, have limited success.
- Novel therapeutic targets for VF prevention are urgently required.
Purpose of the Study:
- To explore the potential of chloride homeostasis manipulation for VF prevention.
- To investigate the role of sarcolemmal membrane resistance in VF suppression.
- To present novel data supporting a new approach to VF prevention.
Main Methods:
- Review of existing data on chloride homeostasis.
- Analysis of experimental data on sarcolemmal membrane resistance.
- Exploration of the link between ion transport and cardiac electrical activity.
Main Results:
- Data supports the hypothesis that altering chloride homeostasis can prevent VF.
- A novel method for VF suppression through modification of sarcolemmal membrane resistance was identified.
- These findings suggest a new pathway for therapeutic intervention in cardiac arrhythmias.
Conclusions:
- Manipulation of chloride homeostasis presents a promising strategy for preventing VF.
- Targeting sarcolemmal membrane resistance offers a novel therapeutic avenue for VF suppression.
- Further research into ion channel function could lead to improved SCD prevention.
Related Concept Videos
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials